Irell Helps Sloan Kettering Institute for Cancer Research and Juno Therapeutics Score $752 Million Jury Award in Patent Suit Against Kite
On December 13, 2019, Irell & Manella LLP convinced a jury in the U.S. District Court for the Central District of California to award Sloan Kettering Institute for Cancer Research and Juno Therapeutics, Inc. $752 million in a patent infringement suit against Kite Pharma Inc. The jury deliberated less than a day before deciding Sloan Kettering and Juno and were entitled to the award. The jury also found that Kite willfully infringed the patent for cancer immunotherapy.
The Irell team includes Morgan Chu, Alan Heinrich, Maclain Wells, Elizabeth Tuan, Michael Fleming, Rebecca Carson and Ingrid Petersen. Jones Day is co-counsel with Irell.